Noncanonical Antiviral Mechanisms of ISGs: Dispensability of Inducible Interferons
Lei Xu,Wenshi Wang,Maikel P. Peppelenbosch,Qiuwei Pan
DOI: https://doi.org/10.1016/j.it.2016.11.002
IF: 19.709
2017-01-01
Trends in Immunology
Abstract:Type I interferons (IFNs) have broad antiviral activities through the induction of IFN-stimulated genes (ISGs). This is considered to constitute the first line of antiviral defense, but excessive exposure to IFNs provokes tissue damage and other pathological events. However, in addition to type I IFNs, the body has other innate antiviral defenses, which were commandingly reviewed by Dr Paludan in a recent issue of Trends in Immunology [ 1 Paludan S.R. Innate antiviral defenses independent of inducible IFNalpha/beta production. Trends Immunol. 2016; 37: 588-596 Abstract Full Text Full Text PDF PubMed Scopus (22) Google Scholar ]. The article highlighted that type I IFN-independent antiviral mechanisms, including alternative antiviral cytokines (e.g., IFN-λ or interleukin 22), or the basal expression of particular ISGs, can mediate early antiviral defenses without evoking the inflammatory damage associated with the production of type I IFNs. However, we feel that, while the constitutively expressed IFN regulatory factors (IRFs) and pattern recognition receptors (PRRs) have been largely examined in the context of the scaling of IFN responses, they also mediate important antiviral mechanisms that are independent of IFN induction and, thus, should also be emphasized. Innate Antiviral Defenses Independent of Inducible IFNα/β ProductionSøren R. PaludanTrends in ImmunologyJune 23, 2016In BriefThe type I interferons (IFNs) (IFNα and IFNβ) not only have potent antiviral activities, but also have pathological functions if produced at high levels or over a long time. Recent articles have described antiviral immune mechanisms that are activated in response to virus infection at epithelial surfaces independently of IFNα and IFNβ. This may allow the host to exert rapid local antiviral activity and only induce a full-blown, and potentially pathological, type I IFN response in situations where stronger protective immunity is needed. Full-Text PDF